Example API Responses
Whatever the format (pam, json, or simple) requested, the API response will always be divided into the following sections:
query
The query that was sent to the server.
apiKey
The apiKey used to issue the request.
result
Contains elements storing the total number of results, the starting point for results and the page size of the results.
records
Contains the individual records that matched the query.
facets
Faceted information about the results.
Example JSON request meta versioned API:
http://api.springernature.com/meta/v2/json?q=doi:10.1007/BF00627098&api_key=yourKeyHere
Response:
{
"apiMessage":"This JSON was provided by Springer Nature",
"query":"doi:10.1007/BF00627098",
"apiKey":"",
"result":[
{
"total":"1",
"start":"1",
"pageLength":"10",
"recordsDisplayed":"1"
}
],
"records":[
{
"contentType":"Article",
"identifier":"doi:10.1007/BF00627098",
"url":[
{
"format":"pdf",
"platform":"web",
"value":"http://link.springer.com/openurl/pdf?id=doi:10.1007/BF00627098"
},
{
"format":"",
"platform":"",
"value":"http://dx.doi.org/10.1007/BF00627098"
}
],
"title":"Electromagnetic radiation outbursts from the collision of P/Shoemaker-Levy 9 comet with Jupiter",
"creators":[
{
"creator":"Lou, Yu -Qing"
}
],
"publicationName":"Astrophysics and Space Science",
"issn":"0004-640X",
"eissn":"1572-946X",
"openaccess":"false",
"journalid":"10509",
"doi":"10.1007/BF00627098",
"publisher":"Springer",
"publicationDate":"1994-12-01",
"onlineDate":"",
"coverDate":"",
"printDate":"",
"volume":"222",
"number":"1-2",
"issuetype":"Combined",
"topicalCollection":"",
"startingPage":"231",
"endingPage":"234",
"copyright":"©1994 Kluwer Academic Publishers",
"genre":"Letter",
"articleCategory":"",
"abstract":"AbstractThe forthcoming collision by debris of P/Shoemaker-Levy 9 comet with Jupiter during the week of July 18, 1994 has generated considerable scientific and public interest. This collision may release an amount of energy ranging from 10^25-10^31 ergs in the Jovian atmosphere. Two possible phenomena associated with this event are described in this Letter to the Editor. The first one is the likely display of deformed Jovian magnetic field lines as the comet interacts with the Jovian magnetosphere. The second one is electromagnetic radiation outbursts during comet explosions over a wide frequency range from radio up to gamma ray emissions. If relativistic electrons with energies up to ~ 1000 MeV could be produced during comet explosions, then synchrotron radiations with frequencies from radio up to infrared range could be detectable. Hard X-rays and gamma rays could be produced by bremsstrahlung and inverse Compton processes. Since one cannot exclude the possible transient presence of relativistic electrons with Lorentz γ factor ≳ 2 × 10^6, synchrotron radiation component might even be extended into gamma ray frequency range during intermittent short time intervals."
}
],
"facets":[
{
"name":"subject",
"values":[
{
"value":"Astrobiology",
"count":"1"
},
{
"value":"Astronomy, Observations and Techniques",
"count":"1"
},
{
"value":"Astrophysics and Astroparticles",
"count":"1"
},
{
"value":"Cosmology",
"count":"1"
},
{
"value":"Physics",
"count":"1"
},
{
"value":"Space Sciences (including Extraterrestrial Physics, Space Exploration and Astronautics)",
"count":"1"
}
]
},
{
"name":"keyword",
"values":[
]
},
{
"name":"pub",
"values":[
{
"value":"Astrophysics and Space Science",
"count":"1"
}
]
},
{
"name":"year",
"values":[
{
"value":"1994",
"count":"1"
}
]
},
{
"name":"country",
"values":[
{
"value":"United States",
"count":"1"
}
]
},
{
"name":"type",
"values":[
{
"value":"Journal",
"count":"1"
}
]
}
]
}
Example PAM meta versioned request:
http://api.springernature.com/meta/v2/pam?q=doi:10.1007/s11276-008-0131-4&api_key=yourKeyHere
Response:
<response>
<apiMessage>This XML was provided by Springer Nature</apiMessage>
<query>doi:10.1007/s11276-008-0131-4</query>
<apiKey></apiKey>
<result>
<total>1</total>
<start>1</start>
<pageLength>10</pageLength>
<recordsDisplayed>1</recordsDisplayed>
</result>
<records>
<record>
<pam:message>
<pam:article>
<xhtml:head>
<dc:identifier>doi:10.1007/s11276-008-0131-4</dc:identifier>
<dc:title>Bit-per-joule performance of power saving ad hoc networks with a mobile backbone</dc:title>
<dc:creator>Huang, Xiaolong</dc:creator>
<dc:creator>Rubin, Izhak</dc:creator>
<prism:publicationName>Wireless Networks</prism:publicationName>
<prism:issn>1022-0038</prism:issn>
<prism:eIssn>1572-8196</prism:eIssn>
<prism:doi>10.1007/s11276-008-0131-4</prism:doi>
<dc:publisher>Springer</dc:publisher>
<prism:coverDate>2010-02</prism:coverDate>
<prism:publicationDate>2010-02-01</prism:publicationDate>
<prism:volume>16</prism:volume>
<prism:number>2</prism:number>
<prism:startingPage>311</prism:startingPage>
<prism:endingPage>329</prism:endingPage>
<prism:url>http://dx.doi.org/10.1007/s11276-008-0131-4</prism:url>
<prism:url prism:platform="web">http://link.springer.com/openurl/fulltext?id=doi:10.1007/s11276-008-0131-4</prism:url>
<prism:url prism:platform="web">http://link.springer.com/openurl/pdf?id=doi:10.1007/s11276-008-0131-4</prism:url>
<prism:genre />
<prism:copyright>©2008 Springer Science+Business Media, LLC</prism:copyright>
</xhtml:head>
<xhtml:body>
<xhtml:h1>Abstract</xhtml:h1>
<xhtml:p>Energy efficient MAC protocols have been developed for wireless sensor and mobile ad hoc networks so that inactive nodes can transition into sleep state to conserve energy. It has been recognized that maintaining a continuously awake connected dominating set (CDS) serves to reduce the route setup latency. Under the mobile backbone network (MBN) architecture introduced by Rubin et al., a mobile backbone (Bnet) is dynamically constructed to provide a topological covering of the network. The MBN employs a hybrid routing algorithm under which flows that travel a distance longer than a threshold are directed along routes across the Bnet. In turn, a limited span network-wide global route discovery process is applied for routing shorter distance flows. In this paper, we introduce and analyze an MBN based power saving protocol (MBN-PS) that employs this hybrid routing scheme. Under the MBN-PS scheme, dynamically elected backbone nodes are kept awake, while inactive non-backbone nodes can reside in sleep state. We analytically show that, when the number of network flows is above a minimal level, the throughput per watt efficiency attained in an ad hoc network under complete backbone coverage is better than that achieved by a corresponding network that does not form a backbone. We present a model for the calculation of the bit-per-joule performance of the network as a function of the distance threshold. We confirm the validity of our analytical approach through simulations. Using our method, a network designer is able to choose the optimal distance threshold to be used by this scheme, based on traffic loading conditions.</xhtml:p>
</xhtml:body>
</pam:article>
</pam:message>
<extendedMeta>
<contentType>Article</contentType>
<journalId>11276</journalId>
<issueType>Regular</issueType>
<topicalCollection />
<openAccess>false</openAccess>
<printDate>2010-01-22</printDate>
<onlineDate>2008-08-30</onlineDate>
</extendedMeta>
</record>
</records>
<facets>
<facet name="subject">
<facet-value count="1">Business Information Systems</facet-value>
<facet-value count="1">Communications Engineering, Networks</facet-value>
<facet-value count="1">Computer Communication Networks</facet-value>
<facet-value count="1">Electrical Engineering</facet-value>
<facet-value count="1">Engineering</facet-value>
</facet>
<facet name="keyword">
<facet-value count="1">Ad hoc networks</facet-value>
<facet-value count="1">Ad hoc routing</facet-value>
<facet-value count="1">Energy efficient protocol</facet-value>
<facet-value count="1">Mobile backbone networks</facet-value>
<facet-value count="1">Performance analysis</facet-value>
<facet-value count="1">Power saving</facet-value>
<facet-value count="1">Systems modeling</facet-value>
</facet>
<facet name="pub">
<facet-value count="1">Wireless Networks</facet-value>
</facet>
<facet name="year">
<facet-value count="1">2010</facet-value>
</facet>
<facet name="country">
<facet-value count="1">United States</facet-value>
</facet>
<facet name="type">
<facet-value count="1">Journal</facet-value>
</facet>
</facets>
</response>
Example metadata JSON request:
http://api.springernature.com/metadata/json?q=name:hughes year:2014&s=1&p=5&api_key=yourKeyHere
Response:
{
"apiMessage":"This JSON was provided by Springer Nature",
"query":"name:hughes year:2014",
"apiKey":"",
"result":[
{
"total":"467",
"start":"1",
"pageLength":"5",
"recordsDisplayed":"5"
}
],
"records":[
{
"contentType":"Article",
"identifier":"doi:10.1186/s12888-014-0370-0",
"url":[
{
"format":"",
"platform":"",
"value":"http://dx.doi.org/10.1186/s12888-014-0370-0"
}
],
"title":"Differentiating ADHD from oral language difficulties in children: role of movements and effects of stimulant medication",
"creators":[
{
"creator":"Hughes, Carroll W"
},
{
"creator":"Pickering, Joyce"
},
{
"creator":"Baker, Kristi"
},
{
"creator":"Bolanos, Gina"
},
{
"creator":"Silver, Cheryl"
}
],
"publicationName":"BMC Psychiatry",
"issn":"1471-244X",
"eissn":"",
"openaccess":"true",
"journalid":"12888",
"doi":"10.1186/s12888-014-0370-0",
"publisher":"BioMed Central",
"publicationDate":"2014-12-31",
"onlineDate":"",
"coverDate":"",
"printDate":"",
"volume":"14",
"number":"1",
"issuetype":"",
"topicalCollection":"",
"startingPage":"1",
"endingPage":"9",
"copyright":"©2014 Hughes et al.; licensee BioMed Central.",
"genre":"OriginalPaper",
"articleCategory":"",
"abstract":"AbstractBackgroundThe current study was designed to test if an objective measure of both attention and movement would differentiate children with Oral Language Disorders (OLD) from those with comorbid Attention Deficit/Hyperactivity Disorder (ADHD) and if stimulant medication improved performance when both disorders were present.MethodsThe sample consisted of thirty-three children with an identified oral language disorder (of which 22 had comorbid ADHD) ages 6 to 13 who were enrolled in a yearlong intensive learning intervention program. Those on a stimulant medication were tested at baseline and again a year later on and off medication.ResultsObjective measures that included an infrared motion analysis system which tracked and recorded subtle movements discriminated children with OLD from those with a comorbid ADHD disorder whereas classic attention measures did not. There were better attention scores and fewer movements in children while on-medication.ConclusionsUse of an objective measurement that includes movement detection improves objective diagnostic differential for OLD and ADHD and provides quantifiable changes in performance related to medication for both OLD and ADHD."
},
{
"contentType":"Article",
"identifier":"doi:10.1186/s12977-014-0122-8",
"url":[
{
"format":"",
"platform":"",
"value":"http://dx.doi.org/10.1186/s12977-014-0122-8"
}
],
"title":"Cross-clade simultaneous HIV drug resistance genotyping for reverse transcriptase, protease, and integrase inhibitor mutations by Illumina MiSeq",
"creators":[
{
"creator":"Dudley, Dawn M"
},
{
"creator":"Bailey, Adam L"
},
{
"creator":"Mehta, Shruti H"
},
{
"creator":"Hughes, Austin L"
},
{
"creator":"Kirk, Gregory D"
},
{
"creator":"Westergaard, Ryan P"
},
{
"creator":"O’Connor, David H"
}
],
"publicationName":"Retrovirology",
"issn":"1742-4690",
"eissn":"",
"openaccess":"true",
"journalid":"12977",
"doi":"10.1186/s12977-014-0122-8",
"publisher":"BioMed Central",
"publicationDate":"2014-12-23",
"onlineDate":"",
"coverDate":"",
"printDate":"",
"volume":"11",
"number":"1",
"issuetype":"",
"topicalCollection":"",
"startingPage":"1",
"endingPage":"15",
"copyright":"©2014 Dudley et al.; licensee BioMed Central.",
"genre":"OriginalPaper",
"articleCategory":"",
"abstract":"AbstractBackgroundViral resistance to antiretroviral therapy threatens our best methods to control and prevent HIV infection. Current drug resistance genotyping methods are costly, optimized for subtype B virus, and primarily detect resistance mutations to protease and reverse transcriptase inhibitors. With the increasing use of integrase inhibitors in first-line therapies, monitoring for integrase inhibitor drug resistance mutations is a priority. We designed a universal primer pair to PCR amplify all major group M HIV-1 viruses for genotyping using Illumina MiSeq to simultaneously detect drug resistance mutations associated with protease, nucleoside reverse transcriptase, non-nucleoside reverse transcriptase, and integrase inhibitors.ResultsA universal primer pair targeting the HIV pol gene was used to successfully PCR amplify HIV isolates representing subtypes A, B, C, D, CRF01_AE and CRF02_AG. The universal primers were then tested on 62 samples from a US cohort of injection drug users failing treatment after release from prison. 94% of the samples were successfully genotyped for known drug resistance mutations in the protease, reverse transcriptase and integrase gene products. Control experiments demonstrate that mutations present at ≥ 2% frequency are reliably detected and above the threshold of error for this method. New drug resistance mutations not found in the baseline sample were identified in 54% of the patient samples after treatment failure. 86% of patients with major drug resistance mutations had 1 or more mutations associated with drug resistance to the treatment regimen at the time point of treatment failure. 59% of the emerging mutations were found at frequencies between 2% and 20% of the total sequences generated, below the estimated limit of detection of current FDA-approved genotyping techniques. Primary plasma samples with viral loads as low as 799 copies/ml were successfully genotyped using this method.ConclusionsHere we present an Illumina MiSeq-based HIV drug resistance genotyping assay. Our data suggests that this universal assay works across all major group M HIV-1 subtypes and identifies all drug resistance mutations in the pol gene known to confer resistance to protease, reverse transcriptase and integrase inhibitors. This high-throughput and sensitive assay could significantly improve access to drug resistance genotyping worldwide."
},
{
"contentType":"Article",
"identifier":"doi:10.1186/1752-1947-8-455",
"url":[
{
"format":"",
"platform":"",
"value":"http://dx.doi.org/10.1186/1752-1947-8-455"
}
],
"title":"Treatment decisions in a man with Hodgkin lymphoma and Guillian-Barré syndrome: a case report",
"creators":[
{
"creator":"Hughes, Caren L"
},
{
"creator":"Yorio, Jeffrey T"
},
{
"creator":"Kovitz, Craig"
},
{
"creator":"Oki, Yasuhiro"
}
],
"publicationName":"Journal of Medical Case Reports",
"issn":"1752-1947",
"eissn":"",
"openaccess":"true",
"journalid":"13256",
"doi":"10.1186/1752-1947-8-455",
"publisher":"BioMed Central",
"publicationDate":"2014-12-21",
"onlineDate":"",
"coverDate":"",
"printDate":"",
"volume":"8",
"number":"1",
"issuetype":"",
"topicalCollection":"",
"startingPage":"1",
"endingPage":"4",
"copyright":"©2014 Hughes et al.; licensee BioMed Central.",
"genre":"OriginalPaper",
"articleCategory":"",
"abstract":"AbstractIntroductionGuillain-Barre syndrome, or acute inflammatory demyelinating polyneuropathy, has been described in the presence of malignancies such as lymphoma. Guillain-Barre syndrome/acute inflammatory demyelinating polyneuropathy causes paresthesias and weakness, which can make the treatment of lymphoma with chemotherapy challenging. Given the rarity of this co-presentation it is not known if the effects of Guillain-Barre syndrome should be considered when selecting a treatment regimen for Hodgkin lymphoma. To the best of our knowledge, the impact of these treatment modifications has not been previously reported.Case presentationWe report the case of a 37-year-old Caucasian man with a diagnosis of stage IIB classical Hodgkin lymphoma with concomitant Guillain-Barre syndrome. Our patient originally presented with an enlarged cervical lymph node and quickly developed distal paresthesia and progressive weakness of all four extremities. He was diagnosed with Hodgkin’s lymphoma and initiated on treatment with doxorubicin, bleomycin, vinblastine, and dacarbazine. Doses of bleomycin and vinblastine were held or dose-reduced throughout his initial treatment course due to underlying neuropathy and dyspnea. He continued to have persistent disease after five cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and went on to receive salvage treatments including more chemotherapy, radiation, autologous stem cell transplant and is currently preparing for an allogeneic stem cell transplant.ConclusionsParaneoplastic syndromes such as Guillain-Barre syndrome/acute inflammatory demyelinating polyneuropathy can make the treatment of patients with Hodgkin lymphoma more challenging and can interfere with delivering full-dose chemotherapy. Further case series are needed to evaluate the effect that paraneoplastic syndromes, or adjustments made in therapy due to these syndromes, negatively affect the prognosis of patients with Hodgkin lymphoma."
},
{
"contentType":"Article",
"identifier":"doi:10.1186/1710-1492-10-S2-A56",
"url":[
{
"format":"",
"platform":"",
"value":"http://dx.doi.org/10.1186/1710-1492-10-S2-A56"
}
],
"title":"Lineage specific role of Ship1 in development of allergic airway inflammation",
"creators":[
{
"creator":"Gold, Matthew J"
},
{
"creator":"Hughes, Michael R"
},
{
"creator":"Antignano, Frann"
},
{
"creator":"Zaph, Colby"
},
{
"creator":"McNagny, Kelly M"
}
],
"publicationName":"Allergy, Asthma \u0026 Clinical Immunology",
"issn":"1710-1492",
"eissn":"",
"openaccess":"true",
"journalid":"13223",
"doi":"10.1186/1710-1492-10-S2-A56",
"publisher":"BioMed Central",
"publicationDate":"2014-12-18",
"onlineDate":"",
"coverDate":"",
"printDate":"",
"volume":"10",
"number":"2",
"issuetype":"",
"topicalCollection":"",
"startingPage":"1",
"endingPage":"1",
"copyright":"©2014 Gold et al; licensee BioMed Central Ltd.",
"genre":"Abstract",
"articleCategory":"",
"abstract":""
},
{
"contentType":"Article",
"identifier":"doi:10.1186/s40545-014-0017-z",
"url":[
{
"format":"",
"platform":"",
"value":"http://dx.doi.org/10.1186/s40545-014-0017-z"
}
],
"title":"Antibiotic repeat prescriptions: are patients not re-filling them properly?",
"creators":[
{
"creator":"Zayegh, Iman"
},
{
"creator":"Charrois, Theresa L"
},
{
"creator":"Hughes, Jeffery"
},
{
"creator":"Hoti, Kreshnik"
}
],
"publicationName":"Journal of Pharmaceutical Policy and Practice",
"issn":"2052-3211",
"eissn":"",
"openaccess":"true",
"journalid":"40545",
"doi":"10.1186/s40545-014-0017-z",
"publisher":"BioMed Central",
"publicationDate":"2014-12-16",
"onlineDate":"",
"coverDate":"",
"printDate":"",
"volume":"7",
"number":"1",
"issuetype":"",
"topicalCollection":"",
"startingPage":"1",
"endingPage":"6",
"copyright":"©2014 Zayegh et al.; licensee BioMed Central.",
"genre":"OriginalPaper",
"articleCategory":"",
"abstract":"AbstractObjectiveThis study aimed to explore patients’ utilization of repeat prescriptions for antibiotics indicated in upper respiratory tract infections (URTI). An emphasis was placed on whether the current system of repeat prescriptions contributes to patients self-diagnosing infections and if so, identify the common reasons for this.MethodsThis is a prospective study of self-reported use of repeat antibiotic prescriptions by pharmacy consumers presenting with repeat prescriptions for antibiotics commonly indicated in URTIs. Data were collected via self-completed surveys in Perth metropolitan pharmacies.ResultsA total of 123 respondents participated in this study from 19 Perth metropolitan pharmacies. Of the respondents, approximately a third of them (33.9%) presented to the pharmacy to fill their antibiotic repeat prescription one month or more from the time the original prescription was written (i.e. time when original diagnosis was made by a doctor). Over two thirds of respondents indicated to not have consulted their doctor prior to presenting to the pharmacy to have their antibiotic repeat prescription dispensed (i.e. 68.3%). The most common reasons for this were that their ‘doctor had told them to take the second course’ (38%), followed by potential self-diagnosis (29%), i.e. ‘they had the same symptoms as the last time they took the antibiotics’. Approximately one third (33.1%) of respondents indicated they ‘were not told what the repeat prescription was needed for’ when they were originally prescribed the antibiotic. Respondents who presented to fill their repeat prescription more than 2 weeks after the original prescription written were more likely not have consulted their doctor (p = 0.006, 95% CI [1.16, 2.01]) and not to know why their repeat was needed (p = 0.010, 95% CI [1.07, 2.18]).ConclusionsFindings of this study suggested that the current 12 month validity of antibiotics repeat prescriptions is potentially contributing to patients’ self-diagnosis of URTIs and therefore potential misuse of antibiotics. This may be contributing to the rise of antimicrobial resistance. The study also outlines some common reasons for patients potentially self-diagnosing URTIs when using repeat prescriptions. Larger Australian studies are needed to confirm these findings."
}
],
"facets":[
{
"name":"subject",
"values":[
{
"value":"Medicine \u0026 Public Health",
"count":"144"
},
{
"value":"Physics",
"count":"87"
},
{
"value":"Elementary Particles, Quantum Field Theory",
"count":"85"
},
{
"value":"Quantum Field Theories, String Theory",
"count":"85"
},
{
"value":"Classical and Quantum Gravitation, Relativity Theory",
"count":"57"
},
{
"value":"Quantum Physics",
"count":"57"
},
{
"value":"Life Sciences",
"count":"55"
},
{
"value":"Biomedicine",
"count":"48"
},
{
"value":"Medicine/Public Health, general",
"count":"33"
},
{
"value":"Hematology",
"count":"31"
},
{
"value":"Oncology",
"count":"31"
},
{
"value":"Public Health",
"count":"30"
},
{
"value":"Astronomy, Astrophysics and Cosmology",
"count":"28"
},
{
"value":"Measurement Science and Instrumentation",
"count":"28"
},
{
"value":"Nuclear Energy",
"count":"28"
},
{
"value":"Nuclear Physics, Heavy Ions, Hadrons",
"count":"28"
},
{
"value":"Education",
"count":"27"
},
{
"value":"Internal Medicine",
"count":"25"
},
{
"value":"Immunology",
"count":"22"
},
{
"value":"Higher Education",
"count":"21"
}
]
},
{
"name":"keyword",
"values":[
{
"value":"Hadron-Hadron Scattering",
"count":"49"
},
{
"value":"Top physics",
"count":"8"
},
{
"value":"Supersymmetry",
"count":"6"
},
{
"value":"Jet physics",
"count":"5"
},
{
"value":"Jets",
"count":"5"
},
{
"value":"Obesity",
"count":"5"
},
{
"value":"Breast cancer",
"count":"4"
},
{
"value":"Higgs physics",
"count":"4"
},
{
"value":"Self-management",
"count":"4"
},
{
"value":"Antiretroviral therapy",
"count":"3"
},
{
"value":"Electroweak interaction",
"count":"3"
},
{
"value":"Exercise",
"count":"3"
},
{
"value":"Extended Supersymmetry",
"count":"3"
},
{
"value":"Head and neck cancer",
"count":"3"
},
{
"value":"Heart failure",
"count":"3"
},
{
"value":"HIV",
"count":"3"
},
{
"value":"Isogeometric analysis",
"count":"3"
},
{
"value":"Mortality",
"count":"3"
},
{
"value":"Potentially inappropriate prescribing",
"count":"3"
},
{
"value":"Primary care",
"count":"3"
}
]
},
{
"name":"pub",
"values":[
{
"value":"Journal of High Energy Physics",
"count":"57"
},
{
"value":"The European Physical Journal C",
"count":"28"
},
{
"value":"Sjögren’s Syndrome in Clinical Practice",
"count":"16"
},
{
"value":"Ipsative Assessment",
"count":"11"
},
{
"value":"Learning Transitions in Higher Education",
"count":"10"
},
{
"value":"Political Economy and the Aid Industry in Asia",
"count":"8"
},
{
"value":"American Black Women and Interpersonal Leadership Styles",
"count":"7"
},
{
"value":"BMC Public Health",
"count":"6"
},
{
"value":"British Dental Journal",
"count":"6"
},
{
"value":"Nature Communications",
"count":"6"
},
{
"value":"Wild Salmonids in the Urbanizing Pacific Northwest",
"count":"6"
},
{
"value":"Handbook of Chronic Myeloid Leukemia",
"count":"5"
},
{
"value":"Journal of Inherited Metabolic Disease",
"count":"5"
},
{
"value":"Osteoporosis International",
"count":"5"
},
{
"value":"Trials",
"count":"5"
},
{
"value":"Environmental Monitoring and Assessment",
"count":"4"
},
{
"value":"Journal of Cardiovascular Magnetic Resonance",
"count":"4"
},
{
"value":"Annals of Surgical Oncology",
"count":"3"
},
{
"value":"BMC Evolutionary Biology",
"count":"3"
},
{
"value":"BMC Infectious Diseases",
"count":"3"
}
]
},
{
"name":"year",
"values":[
{
"value":"2014",
"count":"467"
}
]
},
{
"name":"country",
"values":[
{
"value":"United States",
"count":"242"
},
{
"value":"United Kingdom",
"count":"236"
},
{
"value":"France",
"count":"97"
},
{
"value":"Italy",
"count":"97"
},
{
"value":"Germany",
"count":"96"
},
{
"value":"Switzerland",
"count":"95"
},
{
"value":"Australia",
"count":"93"
},
{
"value":"Brazil",
"count":"91"
},
{
"value":"China",
"count":"89"
},
{
"value":"Austria",
"count":"87"
},
{
"value":"Greece",
"count":"85"
},
{
"value":"Spain",
"count":"85"
},
{
"value":"Colombia",
"count":"84"
},
{
"value":"Czech Republic",
"count":"83"
},
{
"value":"Russia",
"count":"83"
},
{
"value":"Taiwan",
"count":"83"
},
{
"value":"Armenia",
"count":"82"
},
{
"value":"Belarus",
"count":"82"
},
{
"value":"Georgia",
"count":"82"
},
{
"value":"Poland",
"count":"82"
}
]
},
{
"name":"type",
"values":[
{
"value":"Journal",
"count":"354"
},
{
"value":"Book",
"count":"113"
}
]
}
]
}